BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-166

  1. 6,569 Posts.
    lightbulb Created with Sketch. 470
    $200m npat is a nice number but way too confident,
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.